Global Infectious Disease Molecular Diagnostics Market Size To Exceed USD 22.45 Billion By 2035 | CAGR Of 3.22%
Category: HealthcareGlobal Infectious Disease Molecular Diagnostics Market Size To Exceed USD 22.45 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Infectious Disease Molecular Diagnostics Market Size is expected to Grow from USD 15.85 Billion in 2024 to USD 22.45 Billion by 2035, at a CAGR of 3.22% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 Market data tables and figures & charts from the report on the “Global Infectious Disease Molecular Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Reagents, and Services), By Technology (Mass Spectrometry, PCR, In Situ Hybridization, and Others), By Application (Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, and Others), By End-use (Hospitals, Clinics, Diagnostics Laboratories, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/infectious-disease-molecular-diagnostics-market
The infectious disease molecular diagnostics market refers to the industry focusing on the use of molecular biology techniques for detecting and identifying infectious agents, including bacteria, viruses, and parasites. Infectious disease molecular diagnostics involves the application of laboratory techniques that analyze the genetic material of pathogens for diagnosis and characterization of infections. Cutting-edge techniques, including polymerase chain reaction (PCR), nucleic acid amplification, and next-generation sequencing, significantly improve the pathogen detection with high precision is escalating the market growth opportunities. Advancements in molecular diagnostics for enhancing the accuracy, speed, and accessibility are contributing to propel the market growth. On the contrary, the increased cost associated with advanced technologies, uncertain reimbursement policies, and inadequate infrastructure are challenging the market.
The reagents segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the infectious disease molecular diagnostics market is divided into instruments, reagents, and services. Among these, the reagents segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. An increased production and commercialization of innovative reagent formulations is contributing to driving the market growth in the reagents segment.
The PCR segment accounted for the largest market revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the technology, the infectious disease molecular diagnostics market is divided into mass spectrometry, PCR, in situ hybridization, and others. Among these, the PCR segment accounted for the largest market revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. An increasing application of PCR in research and forensic labs, along with the driving need for advanced diagnostics, is contributing to the market growth in the PCR segment.
The respiratory diseases segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the application, the infectious disease molecular diagnostics market is divided into respiratory diseases, tuberculosis, meningitis, gastrointestinal tract infections, HPV, and others. Among these, the respiratory diseases segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The growing prevalence of respiratory diseases, with increased hospitalization rates for urgent demand for diagnosis, is propelling the market.
- The diagnostics laboratories segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end-use, the infectious disease molecular diagnostics market is divided into hospitals, clinics, diagnostics laboratories, and research institutes. Among these, the diagnostics laboratories segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing prevalence of chronic diseases, including cancer, diabetes, and cardiovascular conditions driving the need for diagnostic tests, thereby escalating the market growth.
North America is expected to hold the majority share of the global Infectious disease molecular diagnostics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global infectious disease molecular diagnostics market during the forecast period. An increasing prevalence of communicable and non-communicable disease, with an increasing population of geriatric population, is propelling the market demand. Technological advancements in molecular diagnostics, as well as the incorporation of AI and machine learning, are propelling the market growth of infectious disease molecular diagnostics.
Asia Pacific is anticipated to grow at the fastest pace in the global infectious disease molecular diagnostics market during the forecast period. The growing application of PoC diagnostics tests, along with the rising healthcare expenditure contributing to driving the market growth in the region. Advancements in molecular diagnostics, as well as the development of novel approaches, are contributing to promoting the market.
Europe is anticipated to hold a significant share of the infectious disease molecular diagnostics market during the projected period. The strong investments in diagnostic infrastructure & technology, as well as emphasis on healthcare system improvement, contribute to promoting the market of infectious disease molecular diagnostics.
Major vendors in the global infectious disease molecular diagnostics market are Abbott, Danaher Corporation, Bio-Rad Laboratories, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, Hologic, Inc. (Gen-Probe), Illumina, Inc., Grifols S.A., Qiagen, Siemens Healthineers AG, Sysmex Corporation, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In February 2025, Advanced Biological Laboratories (ABL), a diagnostics company, announced that the licensing and transfer agreement of know-how and IP rights from Fast Track Diagnostics Luxembourg (FTD) had been inked with Siemens Healthineers.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the infectious disease molecular diagnostics market based on the below-mentioned segments:
Global Infectious Disease Molecular Diagnostics Market, By Product
- Instruments
- Reagents
- Services
Global Infectious Disease Molecular Diagnostics Market, By Technology
- Mass Spectrometry
- PCR
- In Situ Hybridization
- Others
Global Infectious Disease Molecular Diagnostics Market, By Application
- Respiratory Diseases
- Tuberculosis
- Meningitis
- Gastrointestinal Tract Infections
- HPV
- Others
Global Infectious Disease Molecular Diagnostics Market, By End-use
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
Global Infectious Disease Molecular Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?